258

ENDOSCOPIC VS. SURGICAL MYOTOMY IN PATIENTS WITH IDIOPATHIC ACHALASIA – FIVE-YEAR FOLLOW UP OF A RANDOMISED TRIAL

Date
May 18, 2024

BACKGROUND
Endoscopic myotomy (POEM) was shown equally effective as laparoscopic Heller myotomy (LHM) in patients with achalasia at two years in a multicenter randomized trial. Postprocedural reflux esophagitis and treatment with acid inhibitors were more frequent after POEM. Here we report treatment success rate and analysis of post-procedural reflux at the five-year follow-up.

METHODS
In a multicenter, randomized trial, we compared POEM with LHM plus Dor’s fundoplication in patients with symptomatic achalasia. The primary end point was clinical success, defined as an Eckardt symptom score of 3 or less without the use of additional treatments at the 5-year follow-up. Secondary end points included esophageal function (manometry, pH-metry), Gastrointestinal Quality of Life Index score, rate of reflux esophagitis and its complications and proportion of patients on proton pump inhibitors.

RESULTS
A total of 221 patients were randomly assigned to undergo either POEM (112 patients) or LHM plus Dor’s fundoplication (109 patients). Five-year follow up data was available in 90 POEM and 86 LHM patients. Clinical success rate at the 5-year follow-up was 75.0% (95% CI: 66.2% to 82.1%) in the POEM group and 70.8% (95% CI: 61.7% to 78.5%) in the LHM group. The difference of 4.2% (95% CI: -7.5% to 15.7%) indicates non-inferiority of POEM at the pre-defined 12.5% margin. Decrease in integrated relaxation pressure of the lower esophageal sphincter at 5 years did not differ between the treatment groups (difference, 0.9 mm Hg; 95% CI, -4.3 to 6.3), nor did improvement in the score on the Gastrointestinal Quality of Life Index (difference, -0.3 points; 95% CI, -8.1 to 6.9). At 5 years, 41.3% of patients (26/63) in the POEM group and 31.0% of patients (18/58) in the LHM group had endoscopic reflux esophagitis (LA C or D 4.8% in the POEM group, n=3, and 3.4% in the LHM group, n=2). The difference between POEM and LHM was not significant (10.2%, 95% CI: -7.0% to 26.8%, p=0.26). At 5 years, 53.4% (47/88) of patients after POEM vs. 38.8% (33/85) after LHM were administered PPIs (difference 14.6%, 95% CI: -0.3% to 28.8%, p=0.07). In those patients in whom gastroesophageal reflux was measured by pH-metry, pathological reflux was significantly more frequent after POEM (51.1%, 23/45) than after LHM (22.2%, 8/36), difference 28.9% (95% CI: 7.7% to 47.3%), p=0.01. Complications such as peptic stricture or Barrett's esophagus were not reported.

CONCLUSIONS
In this randomized trial, POEM was noninferior to LHM plus Dor’s fundoplication in controlling symptoms of achalasia at 5 years. Gastroesophageal reflux was common in both groups, with a tendency of higher rates among POEM patients in some parameters. (Funded by the European Clinical Research Infrastructure Network and others).

Tracks

Related Products

Thumbnail for STUDY ON THE ROLE OF INTESTINAL MUSCULARIS MACROPHAGES IN DIABETIC NEURODEGENERATION
STUDY ON THE ROLE OF INTESTINAL MUSCULARIS MACROPHAGES IN DIABETIC NEURODEGENERATION
INTRODUCTION/AIM: Delayed gastric emptying and constipation related to neurodegeneration are major complications of poorly controlled diabetes. Using scRNAseq, we identified a neuron-associated muscularis macrophage (NA-MM) population expressing F11r (CD321)…
Thumbnail for LONG-TERM RESULTS OF ENDOSCOPIC PYLOROMYOTOMY: FOLLOW-UP OF A RANDOMIZED, SHAM-CONTROLLED TRIAL (GREG)
LONG-TERM RESULTS OF ENDOSCOPIC PYLOROMYOTOMY: FOLLOW-UP OF A RANDOMIZED, SHAM-CONTROLLED TRIAL (GREG)
We previously reported 6 months results of a prospective randomized sham controlled trial comparing endoscopic pyloromyotomy (G-POEM) with a sham procedure in patients with gastroparesis (GREG). G-POEM was superior to sham in terms of symptoms improvement and gastric emptying rate…
Thumbnail for TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Our previous pilot study showed that treatment with the histamine 1 receptor antagonist ebastine improved symptoms in patients with irritable bowel syndrome (IBS)…
Thumbnail for GASTROESOPHAGEAL REFLUX AND ITS SEQUELAE AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM)
GASTROESOPHAGEAL REFLUX AND ITS SEQUELAE AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM)
BACKGROUND: Video analysis has emerged as a potentially strategy for performance assessment of specialized techniques where local expertise and mentorship are limited…